RWMAX
Price
$64.93
Change
+$0.36 (+0.56%)
Updated
Nov 8 closing price
VFFSX
Price
$293.63
Change
+$1.16 (+0.40%)
Updated
Nov 8 closing price
Ad is loading...

RWMAX vs VFFSX

Header iconRWMAX vs VFFSX Comparison
Open Charts RWMAX vs VFFSXBanner chart's image
American Funds Washington Mutual R1
Price$64.93
Change+$0.36 (+0.56%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Institutional Select
Price$293.63
Change+$1.16 (+0.40%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RWMAX vs VFFSX Comparison Chart
Loading...
VS
RWMAX vs. VFFSX commentary
Nov 10, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWMAX is a StrongBuy and VFFSX is a Buy.

FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.28T vs. RWMAX (196B). VFFSX pays higher dividends than RWMAX: VFFSX (1.33) vs RWMAX (0.83). RWMAX was incepted earlier than VFFSX: RWMAX (22 years) vs VFFSX (8 years). RWMAX is a more actively managed with annual turnover of: 30.00 vs. VFFSX (2.00). RWMAX has a lower initial minimum investment than VFFSX: RWMAX (250) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 38.02 vs. RWMAX (24.11). VFFSX return over 5 years is better than : 93.94 vs. RWMAX (39.86).
RWMAXVFFSXRWMAX / VFFSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years8 years-
Gain YTD15.60025.95360%
Front LoadN/AN/A-
Min. Initial Investment25050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets196B1.28T15%
Annual Yield % from dividends0.831.3362%
Returns for 1 year24.1138.0263%
Returns for 3 years11.4828.0841%
Returns for 5 years39.8693.9442%
Returns for 10 years57.05N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VICI31.390.46
+1.49%
VICI Properties
MMV0.37N/A
+0.81%
MultiMetaVerse Holdings Limited
FUL77.79-0.79
-1.01%
HB Fuller Company
FATE2.42-0.13
-5.10%
Fate Therapeutics
PHAT16.86-1.64
-8.86%
Phathom Pharmaceuticals